Gilead’s Trodelvy Faces Setback with Bladder Cancer Trial Failure and Concerns over Early Deaths

AbbVie Highlights Strong Solid Tumor Pipeline at ASCO 2024 with New ADC Platform Data

BioNTech Invests $25M Upfront to Enhance ADC Partnership with China’s MediLink

AstraZeneca and Daiichi Sankyo’s ADC Falls Short in Phase III NSCLC Trial